Refine your search

Content type
Tags
Firm name
Author
Jurisdiction
Language

379 results found

Article
Ask Lexy

Mintz | USA | 24 Jan 2024

How Compulsory Licenses Can Affect Domestic and Foreign Prosecution

Compulsory licensing is a practice that allows a third party to produce or use a Patented product or process without the consent of the patent owner…
Article
Ask Lexy

Accura Advokatpartnerselskab | Russia | 27 Jun 2023

Can IP rights still be protected in Russia?

The short answer is yes. In general, it is business as usual when it comes to the protection of IP in Russia. Despite the earlier rumors of counter…
Article
Ask Lexy

Taylor Wessing | European Union | 5 Jun 2023

Commission proposal on a Union compulsory license

Following a public consultation in 2022, the Commission has provided a draft regulation for a Union compulsory license (Regulation COM(2023)224)…
Article
Ask Lexy

Taylor Wessing | Germany | 16 Mar 2023

Disproportionality in Pharma-Cases: A Follow-up

Last summer, the Dusseldorf District Court refused a Defendant’s disproportionality defence based on Sec. 139 (1) 3rd sentence German Patent Act…
Article
Ask Lexy

McDermott Will & Emery | USA | 20 Oct 2022

When Are Compulsory Copyright Licenses Compulsory?

The US Court of Appeals for the Second Circuit partially affirmed a district court’s summary judgment order holding that audiovisual recordings of…
Article
Ask Lexy

Gün + Partners | Turkey | 11 Oct 2022

Why compulsory licensing is a blunt instrument in the post-covid landscape

Earlier this year the Turkish minister of health announced that President Recep Tayyip Erdogan had made a compulsory licence decision about the…
Commentary
Ask Lexy

IP Law Galli | Italy | 27 Jun 2022

Revision of Italian IP code: university patents return to universities and digitisation continues

The Italian Council of Ministers has approved a draft law to amend several provisions of the Industrial Property Code. Some significant potential novelties concerning administrative simplification and digitisation of procedures have to be pointed out. Even more significant – albeit in need of improvement – is the restitution to universities (both public and private) and other public research......
Article
Ask Lexy

Van Bael & Bellis | Belgium | 23 Jun 2022

Belgian Government Think-Tank Publishes Study on Compulsory Licensing for Expensive Medicines

On 14 June 2022, the Belgian Health Care Knowledge Centre (KCE), a research institute funded by the federal government, published a study discussing…
Commentary
Ask Lexy

Mirandah Asia | Thailand | 22 Nov 2021

Thailand rejects covid-19 drug granted by European Patent Office and US Patent and Trademark Office

Favipiravir is a broad-spectrum antiviral drug used in the treatment of multiple diseases and is the first drug that has been approved by various countries as an emergency treatment for covid-19. Thailand's Department of Intellectual Property has rejected a Thai patent application filed under the compulsory licence system for a specific formulation of Favipiravir in tablet form.
Article
Ask Lexy

Taylor Wessing | Germany | 7 Apr 2020

Zwangslizenzen und staatliche Benutzungsanordnungen für Patente

Einschränkungen für Patentinhaber zur Wahrung des öffentlichen Interesses an der ausreichenden Verfügbarkeit notwendiger Arzneimittel Prinzip: Der…
Previous page 1 2 3 ...